Medicare Payment Demo Would Put Often-Prescribed Cancer Drugs ‘Underwater’

Community oncology practices and hospitals strongly object to CMS’ plan for testing different reimbursement formula Part B drugs, which is expected to particularly impact treatments for cancer, arthritis and eye disease.